IPO Calendar

Company Symbol proposed Lead Managers Shares (Millions) Price Low Price High Est. $ Volume Expected to Trade SCOOP Rating Rating Change
Bicara Therapeutics BCAX Morgan Stanley/ TD Cowen/ Cantor/ Stifel 17.5 18.00 18.00 $ 315.0 mil 9/13/2024 Priced S/O S/O
MBX Biosciences MBX JPMorgan/ Jefferies/ Stifel/ Guggenheim Securities 10.2 16.00 16.00 $ 163.2 mil 9/13/2024 Priced S/O S/O
Zenas BioPharma Inc. ZBIO Morgan Stanley/ Jefferies/ Citigroup/ Guggenheim Securities 13.2 17.00 17.00 $ 225.0 mil 9/13/2024 Priced S/O S/O
Read more

Last 100 IPOs - September 14, 2024

Number of IPOs priced : 100
Number Up: 49
Number Down: 49
Number Unchanged: 2
Percentage Change From Issue Price: 8.61%
Percentage Change for The Nasdaq Composite -100.00%

2024 IPO Scorecard - September 14, 2024

Number of IPOs priced (Excluding 32 units) : 115
Number Up: 55
Number Down: 58
Number Unchanged: 2
Total Return From Issue Price: 9.37%
The Nasdaq Composite Index YTD % Change -100.00%